Associations between constipation risk and lifestyle, medication use, and affective symptoms in patients with schizophrenia: a multicenter cross-sectional study
Social Psychiatry and Psychiatric Epidemiology · 2025
DOI: 10.1007/s00127-024-02729-8 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Social Psychiatry and Psychiatric Epidemiology, 2025. Verfasst von Che-Yu Chiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family and Community Medicine, Cathay General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Constipation, Schizophrenia, Antipsychotic Agents, Life Style. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Yang Ming Chiao Tung University.
Abstract (Originalsprache)
Purpose
To investigate the association between lifestyle and atypical antipsychotic drug use in patients with schizophrenia and the risk of constipation and to assess the impact of anxiety and depressive symptoms on constipation risk.
Methods
Cross-sectional convenience sampling was employed, and 271 participants aged 20–65 were enrolled. Data were collected via a structured questionnaire comprising participants’ demographic data, medication information, dietary behavior assessment, and the Baecke Physical Activity Questionnaire, Beck Depression Inventory-II, and Beck Anxiety Inventory. IBM SPSS 24.0 with multivariate logistic regression was used for data analysis. We performed a subgroup analysis of anticholinergic drugs via multivariate logistic regression.
Results
In total, 180 participants had functional constipation; risk factors included female sex, anxiety symptoms, depressive symptoms, and quetiapine and aripiprazole use. Patients who drank more than 3,000 cc of water daily or used risperidone were less likely to have functional constipation. Depressive and anxiety symptoms were risk factors even after adjusting for sex, use of anticholinergics and laxatives, consuming two servings of fruit, consuming three servings of vegetables, consuming more than 3,000 cc of water daily, physical activity, medical comorbidity, chlorpromazine equivalent dose, and atypical antipsychotic use. Similar associations were found for two affective symptoms and functional constipation in the subgroup analysis of anticholinergic drugs.
Conclusion
The prevalence of functional constipation in patients with schizophrenia was 66.4%. The risk factors included female sex, anticholinergics, aripiprazole, quetiapine, and depressive and anxiety symptoms. Risperidone users and those who drank 3000 cc of water daily were less likely to have constipation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family and Community Medicine, Cathay General Hospital, Taipei, Taiwan.
- National Yang Ming Chiao Tung University, Taipei, Taiwan.
- College of Public Health, University of South Florida, Tampa, FL, USA.
- National Yang Ming Chiao Tung University, Taipei, Taiwan. cyyang530904@nycu.edu.tw.
Förderung
- National Science and Technology Council
- National Yang Ming Chiao Tung University
Zitieren
APA
Chiang, C. Y., Lo, S. C., Beckstead, J. W., & Yang, C. Y. (2025). Associations between constipation risk and lifestyle, medication use, and affective symptoms in patients with schizophrenia: a multicenter cross-sectional study. Social Psychiatry and Psychiatric Epidemiology. https://doi.org/10.1007/s00127-024-02729-8
Vancouver
Chiang CY, Lo SC, Beckstead JW, Yang CY. Associations between constipation risk and lifestyle, medication use, and affective symptoms in patients with schizophrenia: a multicenter cross-sectional study. Social Psychiatry and Psychiatric Epidemiology. 2025. doi:10.1007/s00127-024-02729-8
BibTeX
@article{Chiang2025,
author = {Chiang, Che-Yu and Lo, Su-Chen and Beckstead, Jason W and Yang, Chiu-Yueh},
title = {Associations between constipation risk and lifestyle, medication use, and affective symptoms in patients with schizophrenia: a multicenter cross-sectional study},
journal = {Social Psychiatry and Psychiatric Epidemiology},
year = {2025},
doi = {10.1007/s00127-024-02729-8}
}
EUVIMED